News
CYTO
2.960
-1.00%
-0.030
Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results
Benzinga · 01/27 19:31
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/27 18:19
US Stocks Higher; Dow Rises 150 Points
Benzinga · 01/27 15:17
Inozyme, CVRx top healthcare gainers; Nemaura, Marker among losers
Seeking Alpha · 01/27 15:00
Altamira falls amid plans to increase share capital
Seeking Alpha · 01/27 14:29
BRIEF-Altamira Therapeutics Provides Business Update
Reuters · 01/27 14:16
Altamira Therapeutics Says Positive Outlook For 2023, And Our Transformation Into A Pureplay Rna Therapeutics Company, Remains Unchanged Even Though Our Timeline Has Shifted Into The New Year
Benzinga · 01/27 13:52
Altamira Therapeutics Provides Business Update; Company Is Striving To Sell Or Partner Its Other Legacy Assets, Inner Ear Therapeutics; Agreed Upon Sale Assets To The European Family Office Did Not Close As The Buyer Was Not Able To Secure Financing
Benzinga · 01/27 13:51
CYTO Craters after COVID-19 Drug Flub
TipRanks · 01/24 20:54
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
Benzinga · 01/24 19:26
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 01/24 18:11
Altamira falls 26% after acute COVID-19 therapy fails to meet main goal in trial
Seeking Alpha · 01/24 15:29
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
Benzinga · 01/24 15:07
Baudax, bioAffinity top healthcare gainers; Altamira, Tenax lead losers' pack
Seeking Alpha · 01/24 15:00
BRIEF-Altamira Therapeutics Provides Update On Clinical Trials With Bentrio
Reuters · 01/24 13:29
Altamira Therapeutics Provides Update On Clinical Trials With Bentrio; Interim Analysis Shows Superior Efficacy Of Bentrio In Seasonal Allergic Rhinitis
Benzinga · 01/24 13:18
Altamira Therapeutics Provides Year-End 2022 Business Update; Promoted Covadonga Pañeda, From Chief Development Officer To Chief Operating Officer
Benzinga · 12/19/2022 13:51
BRIEF-Altamira Therapeutics Files Prospectus Relates To Resale Of Up To 400,000 Common Shares
Reuters · 12/16/2022 22:00
Altamira Therapeutics Reaches Midpoint For Enrollment In Clinical Trial With Bentrio In Seasonal Allergic Rhinitis In Australia
Benzinga · 12/02/2022 13:59
Altamira Therapeutics Achieves Midpoint Enrollment in Bentrio Trial for Allergic Rhinitis
Altamira Therapeutics Achieves Midpoint Enrollment in Bentrio Trial for Allergic Rhinitis
MT Newswires · 12/02/2022 11:27
More
Webull provides a variety of real-time CYTO stock news. You can receive the latest news about Altamira Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CYTO
Auris Medical Holding AG is a Switzerland-based biotechnologyompany focused on developing and commercializing therapeutics and medical devices for neurotology, rhinology and allergy and central nervous system (CNS) disorders.The Company is active in active in three areas such as: the development of oligonucleotides for extrahepatic therapeutic targets - OligoPhore platform; nasal sprays for protection against airborne viruses and allergens Bentrio or the treatment of vertigo AM-125 ; he development of therapeutics for intratympanic treatment of tinnitus Keyzilen or hearing loss Sonsuvi .